2020 annual financial data
Royalty Pharma 2020 Net income growth
Direct answer
Net income growth was -58.48%.
Operating income was 1,595,399,000 USD and net income was 975,040,000 USD.
Operating cash flow was 2,034,629,000 USD.
Get free Royalty Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,122,353,000 USD
- Operating income
- 1,595,399,000 USD
- Net income
- 975,040,000 USD
- Operating cash flow
- 2,034,629,000 USD